5 Needs context
A Nature paper showed that during fasting, the gut microbiome more actively converts bile into beneficial signaling molecules and short-chain fatty acids.
"there's a Nature paper on this from another group that I reviewed, that when you're fasting, your microbiome is more actively converting bile into healthy molecules as well as short-chain fatty acids. There's a lot of literature on that." (said at 0:32:14)
Preclinical studies and narrative reviews indicate that fasting or intermittent fasting modulates the gut microbiome, enhancing the generation of certain secondary bile acid signaling metabolites and short-chain fatty acids (SCFAs). However, the claim requires biochemical and evidentiary context: SCFAs are produced via microbial fermentation of complex carbohydrates and host mucin, not by the enzymatic conversion of bile acids. Furthermore, while high-impact journals have investigated intestinal bile acid and microbiome dynamics, evidence demonstrating direct metabolic enhancement in humans remains preliminary and largely derived from animal models or small cohorts.
- supports: Fasting and refeeding triggers specific changes in bile acid profiles and gut microbiota. (Journal of diabetes 2023) · cited 24x in the literature
"Compared with the controls, unconjugated primary BAs (PBAs) and unconjugated secondary BAs (SBAs) in plasma were decreased whereas conjugated SBAs in plasma, unconjugated PBAs, unconjugated SBAs and conjugated SBAs in feces, and unconjugated SBAs in liver were increased in the fasting mice." (abstract, results, passage verified)
pubmedfull study (doi) - context: Profiling the human intestinal environment under physiological conditions. (Nature 2023) · cited 472x in the literature
"Correlations between gradients in bile acid concentrations and microbial abundance predicted species that altered the bile acid pool through deconjugation. Furthermore, microbially conjugated bile acid concentrations exhibited amino acid-dependent trends that were not apparent in stool." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Intermittent Fasting and Probiotics for Gut Microbiota Modulation in Type 2 Diabetes Melli… (Nutrients 2025) · cited 4x in the literature
"IF consistently increases Akkermansia muciniphila and, variably, Faecalibacterium prausnitzii abundance, restores microbial circadian rhythmicity, and enhances SCFA and secondary bile acid production." (abstract, results, passage verified)
pubmedfull study (doi)
The American Medical Association evaluated the balance of stomach bleeding risks against cardiovascular event reduction and concluded against generalized baby aspirin use for the broad population.
"The American Medical Association weighed the risk of stomach bleeding and other complications versus lowering the amount of risk of cardiovascular events and came to the conclusion that looking across everybody it doesn't make sense." (said at 1:05:08)
The speaker accurately describes the substantive conclusion of major US clinical guidelines, but attributes the decision to the American Medical Association (AMA) rather than the US Preventive Services Task Force (USPSTF) (whose recommendation statement was published in the Journal of the American Medical Association, JAMA) and the American College of Cardiology/American Heart Association (ACC/AHA). In 2022, the USPSTF concluded after extensive systematic review and microsimulation modeling that routine low-dose aspirin for primary prevention across the general population is not supported: in adults aged 60 and older, initiating aspirin carries no net benefit due to gastrointestinal bleeding and intracranial hemorrhage risks, and in adults aged 40 to 59 with elevated cardiovascular risk (>=10%), the net benefit is small and requires individualized clinical decision-making.
Sinclair's lab published a paper in 2012 demonstrating that diminished blood flow is a pernicious driver of aging and can be reversed with NMN via SIRT1.
"in 2012 we published a paper that showed that one of the most pernicious causes of aging is low blood flow. And then we could reverse that with NMN through SIRT1, more blood flow." (said at 1:13:42)
The speaker is referring to a paper from his laboratory published in Cell in 2018 (Das et al., PMID 29570999), rather than 2012. The study demonstrated in mice that vascular aging involves endothelial NAD+ decline, and treatment with the NAD+ booster nicotinamide mononucleotide (NMN) restored capillary density and improved blood flow and exercise endurance via SIRT1 signaling. Because these findings are derived from preclinical rodent models, human clinical efficacy remains unproven.
High doses of vitamin C taken continuously can act as a pro-oxidant rather than an antioxidant.
"So vitamin C can be pro-oxidation, not antioxidant, if you take a lot continuously." (said at 1:35:37)
Vitamin C exhibits concentration-dependent redox activity: at physiological concentrations it functions primarily as an antioxidant, whereas at high, supraphysiological concentrations (such as those achieved via high-dose intravenous infusions or high-concentration in vitro models), it can act as a pro-oxidant by generating reactive oxygen species such as hydrogen peroxide. However, achieving true pro-oxidant concentrations in vivo generally requires pharmacological (intravenous) administration due to tight intestinal absorption and renal clearance limits for oral vitamin C.
Cycling pressure in hyperbaric oxygen therapy has demonstrated evidence of benefiting brain blood flow and wound healing.
"There's good evidence that certainly cycling uh up and down in pressure is good for the brain and blood flow and have done it myself and uh have seen improvements in wound healing in others." (said at 1:55:28)
Standard hyperbaric oxygen therapy (HBOT) protocols that enhance cerebral blood flow and stimulate tissue repair do not cycle barometric pressure up and down within a session; rather, they maintain a stable elevated chamber pressure (e.g., 1.5–2.4 ATA) and cycle inspired oxygen levels with intermittent 'air breaks' (the hyperoxic-hypoxic paradox). Repeated cycling of physical pressure within a session would introduce barotrauma and decompression risks without clinical rationale. While repeated intermittent HBOT sessions have preliminary evidence showing increased regional cerebral blood flow and established roles in specific non-healing wounds, the benefit is driven by oxygen fluctuations rather than pressure cycling.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.